Literature DB >> 29767581

Lethal hepatotoxicity following 5-fluorouracil/cisplatin chemotherapy: a relevant case report.

Aline Hajj1, Marwan Ghosn2, Diane Mourad1, Khalil Hojaiban1, Perla Mousallem1, Lydia Rabbaa Khabbaz1.   

Abstract

Some articles have reported severe toxicities induced by cisplatin/5-fluorouracil regimens, nevertheless, severe and lethal liver toxicity has not been previously reported. In this article, we report the case of a 72-year-old woman, who developed fulminant hepatitis, hypoglycemia and hypotension with atrial fibrillation not responding to treatment. After ruling out all other possible causes of hepatitis, the toxicity was more likely attributed to 5-fluorouracil. Genotyping was performed and the patient was found to be a homozygote carrier of the T variant of the MTHFR gene. The patient died two days later. Several factors, including genetic factors, could explain this severe toxicity. The present case discusses the importance of personalized medicine in oncology based on pharmacogenetic analysis of polymorphisms.

Entities:  

Keywords:  5-fluorouracil; DPYP; MTHFR; cisplatin; lethal hepatotoxicity; pharmacogenetics; polymorphisms; toxicity

Mesh:

Substances:

Year:  2017        PMID: 29767581     DOI: 10.2217/pme-2016-0085

Source DB:  PubMed          Journal:  Per Med        ISSN: 1741-0541            Impact factor:   2.512


  1 in total

1.  A case of severe hepatotoxicity induced by cisplatin and 5-fluorouracil.

Authors:  Ayaka Yaegashi; Kensuke Yoshida; Naoto Suzuki; Izumi Shimada; Yusuke Tani; Yasuo Saijo; Akira Toyama
Journal:  Int Cancer Conf J       Date:  2019-11-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.